Logo 01A (Aggrenox 25 mg / 200 mg)
Generic Name: aspirin/dipyridamole
Pill imprint Logo 01A has been identified as Aggrenox 25 mg / 200 mg.
Aggrenox is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aggrenox 25 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo 01A
- 25 mg / 200 mg
- Red & White
- 24.00 mm
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00054-0575||Roxane Laboratories, Inc.|
|54868-5143||Physicians Total Care Inc (repackager)|
|49999-0919||Lake Erie Medical and Surgical Supply (repackager)|
|21695-0656||Rebel Distributors Corp (repackager)|
|68258-6981||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about Aggrenox (aspirin / dipyridamole)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.